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Abstract
A series of amphiphilic nitric oxide (NO)-releasing poly(amidoamine) (PAMAM) dendrimers
with different exterior functionalities were synthesized by a ring-opening reaction between
primary amines on the dendrimer and propylene oxide (PO), 1,2-epoxy-9-decene (ED), or a ratio
of the two, followed by reaction with NO at 10 atm to produce N-diazeniumdiolate-modified
scaffolds with a total storage of ~1 μmol/mg. The hydrophobicity of the exterior functionality was
tuned by varying the ratio of PO and ED grafted onto the dendrimers. The bactericidal efficacy of
these NO-releasing vehicles against established Gram-negative Pseudomonas aeruginosa biofilms
was then evaluated as a function of dendrimer exterior hydrophobicity (i.e., ratio of PO/ED), size
(i.e., generation), and NO release. Both the size and exterior functionalization of dendrimer proved
important to a number of parameters including dendrimer-bacteria association, NO delivery
efficiency, bacteria membrane disruption, migration within the biofilm, and toxicity to mammalian
cells. Although enhanced bactericidal efficacy was observed for the hydrophobic chains (e.g.,
ED), toxicity to L929 mouse fibroblast cells was also noted at concentrations necessary to reduce
bacterial viability by 5-logs (99.999% killing). The optimal PO to ED ratios for biofilm
eradication with minimal toxicity against L929 mouse fibroblast cells were 7:3 and 5:5. The study
presented herein demonstrated the importance of both dendrimer size and exterior properties in
determining efficacy against established biofilms without compromising biocompatibility to
mammalian cells.
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Introduction
Bacteria in nature exist in two states – free-floating planktonic bacteria and bacterial
biofilms.1 While many antimicrobial agents have proven effective against planktonic
bacteria, medically relevant infections including those associated with medical implants,
diabetes mellitus, and cystic fibrosis are often caused by bacterial biofilms.1–3 In contrast to
planktonic bacteria, biofilms are communities of microorganisms and protected by a self-
secreted exopolysaccharides (EPS) matrix.4 Along with inhibiting the penetration of
antibiotics, biofilms exhibit several other defense mechanisms including overexpression of
stress-responsive genes, oxygen gradients within the EPS matrix, and differentiation of
bacteria into resistant dormant species.4 Collectively, these effects result in greater
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resistance of bacteria within biofilms to antimicrobial agents compared to their planktonic
counterparts. It has been shown that killing bacteria in biofilms may require up to 1000
times the antibiotic dose necessary for killing planktonic bacteria.1 As such, new
antimicrobial agents capable of eradicating mature biofilms are urgently needed.
Dendrimers, a family of macromolecular scaffolds with hyper-branched architectures and
multivalent surfaces,5–18 exhibit antibacterial activity against both planktonic bacteria19–23
and biofilms.24–26 For example, quaternary ammonium-functionalized poly(propylenimine)
(PPI) dendrimers20 and primary amine-functionalized poly(amidoamine) (PAMAM)
dendrimers19 display be biocidal activity against planktonic Pseudomonas aerugionsa and
Staphylococcus aureus. Unfortunately, the inherent toxicity of these scaffolds to eukaryotic
(e.g., mammalian) cells has slowed their development as therapeutics.27 In order to reduce
toxicity to mammalian cells, Grinstaff et al. synthesized anionic amphiphilic polyester
dendrimers that were effective (bactericidal) against Gram-positive Bacillus subtilis but not
cytotoxic to human umbilical vein endothelial cells (HUVECs).21 Likewise, hydroxyl-,
carboxyl-, and poly(ethylene glycol) (PEG)-functionalized PAMAM dendrimers have been
designed to minimize toxicity towards mammalian cells while retaining their antibacterial
efficacy against bacterial species.22, 28 Although most work to date has focused on the
planktonic antibacterial activity of dendrimers, the efficacy of dendritic scaffolds against
more challenging systems, including antibiotic-resistant bacteria and biofilms, has become
an important focus in the continued development of antibacterial dendrimers. Several studies
have demonstrated the dispersion and inhibition of Pseudomonas aeruginosa and
Escherichia coli biofilms by amphiphilic dendritic glycopeptides.24–26, 28 As opposed to
linear antibacterial peptides, dendritic peptides exhibit enhanced inhibition of biofilm
growth.24 However, additional work is required to elucidate the potential of dendrimers as
effective agents for both inhibiting biofilm growth and eradicating mature biofilms.
Nitric oxide (NO), an endogenously-produced diatomic free radical, plays a key role in
human physiology and our natural immune response to pathogens.29–31 Both NO and its
reactive byproducts (e.g., peroxynitrite and dinitrogen trioxide) exert significant oxidative
and nitrosative stress on bacteria to facilitate killing. While nitrosative stress occurs when
thiols on proteins and DNA are nitrosated-impairing normal function, oxidative stress is
mostly observed through lipid peroxidation, which destroys the integrity of bacterial
membrane/envelope.31 Importantly, NO exhibits broad-spectrum antibacterial activity,
making NO-based therapeutics an emerging opportunity. For addressing inadequate
development of new antibiotics, we and others have developed macromolecular vehicles
(e.g., gold nanoparticles, silica nanoparticles, and dendrimers) that are allowed for
controlled NO storage and release.32–40 These materials have proven effective at killing both
Gram–positive and –negative bacteria.41–46 Nitric oxide-releasing dendrimes in particular
exhibit very efficient bactericidal action due to large NO payloads and favorable dendrimer–
bacteria association.44 Sun et al. reported that both the size (i.e., generation) and the exterior
functionality significantly influenced biocidal activity.44 Herein, we report the synthesis of
NO-releasing amphiphilic dendrimers with tunable exterior hydrophobicity to eradicate
bacterial biofilms with minimal impact to mammalian cells.
Experimental Section
Materials
Phenazine methosulfate (PMS), 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt (MTS), trypsin,
phosphate buffered saline (PBS), penicillin streptomycin (PS), rhodamine B isothiocyanate
(RITC), Dulbecco’s modified Eagle’s medium (DMEM), and propidium iodide (PI) were
purchased from Sigma-Aldrich (St. Loius, MO). Sodium methoxide (5.4 M solution in
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methanol), propylene oxide (PO), and 1,2-epoxy-9-decene (ED) were obtained from Acros
Organics (Geel, Belgium). Tryptic soy broth (TSB) and tryptic soy agar (TSA) were
obtained from Becton, Dickison and Company (Franklin Lakes, NJ). Spectra/Por Float-A-
Lyzers for dialysis of the dendrimers were purchased from Spectrum Laboratories, Inc.
(Rancho Dominguez, CA). 4,5-Diaminofluorescein diacetate (DAF-2 DA) was purchased
from Calbiochem (San Diego, CA). Syto 9 green fluorescent nucleic acid stain was
purchased from Life Technologies (Grand Island, NY). Glass bottom microscopy dishes
were received from MatTek Corporation (Ashland, MA). Common laboratory salts and
solvents were purchased from Fisher Scientific (Pittsburgh, PA). Unless noted otherwise,
these and other materials were used as received without further purification.
Synthesis of Secondary Amine- and N-Diazeniumdiolate-Functionalized PAMAM
Dendrimers
Secondary amine-functionalized PAMAM dendrimers (generation 1 or G1 and generation 3
or G3) were synthesized as described previously.32 Briefly, primary amine-functionalized
G1-PAMAM dendrimer (100 mg) was dissolved in methanol (2 mL). One molar equivalent
of PO, ED, or a mixture of PO and ED relative to the primary amines was then added to the
G1-PAMAM-NH2 solution under constant stirring at room temperature for 4 d to yield the
secondary amine-functionalized G1-PAMAM conjugates. Similarly, secondary amine-
functionalized G3-PAMAM conjugates were formed via the reaction of G3-PAMAM-NH2
with PO, ED, or a mixture of PO and ED, respectively. Following 3 d of reaction, solvent
was removed under reduced pressure. The dendrimers were then washed with ethanol,
followed by dialysis against water and lyophilization. The resulting secondary amine-
functionalized dendrimers (G1 and G3) were characterized by nuclear magnetic resonance
(NMR) spectroscopy in deuterated methanol.
Representative 1H NMR data of secondary amine-functionalized G1-PAMAM conjugates
formed via the reactions of G1-PAMAM-NH2 with PO, ED and PO/ED mixtures yielded the
following peaks: G1-PAMAM-PO: 1H NMR (400 MHz, CD3OD, δ): 3.82
(CH2NHCH2CH(OH)CH3), 3.10–3.20 (CONHCH2CH2), 2.75 (CH2N(CH2CH2CO)2), 2.60
(CH2NHCH2CH(OH)CH3), 2.55 (CH2N(CH2CH2CO)2), 2.37 (CH2N(CH2CH2CO)2), 1.00
(CH2NHCH2CH(OH)CH3). G1-PAMAM-ED: 1H NMR (400 MHz, CD3OD, δ): 5.80
(CH2CH=CH2), 4.88 (CH2CH=CH2), 3.58 (NHCH2CH(OH)CH2), 3.10–3.20
(CONHCH2CH2), 2.73 (CH2N(CH2CH2CO)2), 2.67 (NH(CH2)2), 2.55
(CH2N(CH2CH2CO)2), 2.36 (CH2N(CH2CH2CO)2), 1.98 (CH2CH=CH2), 1.2–1.4
(CH2)5CH2CH=CH2). G1-PAMAM-PO/ED: 1H NMR (400 MHz, CD3OD, δ): 5.80
(CH2CH=CH2), 4.88 (CH2CH=CH2), 3.82 (CH2NHCH2CH(OH)CH3), 3.58
(NHCH2CH(OH)CH2), 3.10–3.20 (CONHCH2CH2), 2.75 (CH2N(CH2CH2CO)2), 2.60
(CH2NHCH2CH(OH)CH3), 2.55 (CH2N(CH2CH2CO)2), 2.37 (CH2N(CH2CH2CO)2), 1.98
(CH2CH=CH2), 1.2–1.4 (CH2)5CH2CH=CH2), 1.00 (CH2NHCH2CH(OH)CH3).
N-diazeniumdiolate-functionalized PAMAM dendrimers were synthesized by adding one
equivalent of 5.4 M sodium methoxide solution in methanol (with respect to the molar
amount of primary amine functionality in PAMAM-NH2 used to synthesize dendrimers) to a
vial containing dendrimers (100 mg) in methanol (1 mL). The glass vials were then inserted
in a stainless steel reactor, and the headspace in the reactor was subsequently flushed with
argon three times followed by three longer purges with argon (3 × 10 min) to remove
oxygen from the stirred solution. The reactor was then filled with NO (purified over KOH
pellets for 30 min to remove trace NO degradation products) to 10 atm for 3 d. Unreacted
NO was then removed using the same argon flushing procedure described above to obtain
the N-diazeniumdiolate-modified PAMAM dendrimers.
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Characterization of NO Storage and Release
Nitric oxide release was measured using a Sievers 280i Chemiluminesce Nitric Oxide
Analyzer (Boulder, CO) by adding NO-releasing dendrimers (1 mg) to a sample containing
deoxygenated PBS (30 mL) (pH = 7.4, 37 °C). Nitrogen was purged through the sample
vessel solution to carry liberated NO to the analyzer at a flow rate of 70 mL/min. Additional
nitrogen flow was supplied to the vessel to match the collection rate of the analyzer (200
mL/min). Nitric oxide release was measured in real time, thus allowing for the determination
of NO release total (t[NO]), half-life (t1/2), and maximum NO flux ([NO]max). The analysis
was terminated when the NO release levels fell to below 10 ppb NO/mg dendrimer.
Planktonic Bactericidal Assays Under Static Conditions
Bacterial cultures were grown from a frozen (−80 °C) stock overnight in TSB at 37 °C. A
500 μL aliquot of the resulting suspension was added to fresh TSB (50 mL) and incubated at
37 °C for ~2 h until the concentration reached 1×108 colony forming units (CFU)/mL, as
confirmed by the OD600. A working bacterial stock was generated by plating the bacterial
suspension on TSA and incubating at 37 °C overnight. Subsequent TSA bacterial stocks
were prepared weekly and stored at 4 °C. For bactericidal assays, colonies of P. aeruginosa
were taken from the TSA plate, dispersed in TSB (3 mL), and then incubated at 37 °C
overnight. A 500 μL aliquot of culture was added to fresh TSB (50 mL) and incubated to a
concentration of ~1×108 CFU/mL. The bacteria was then collected by centrifugation (3645
× g for 10 min), resuspended in PBS, and diluted 100-fold to obtain a final concentration of
1×106 CFU/mL. The bactericidal efficacy of NO-releasing dendrimers against the bacteria
was evaluated by incubating the bacteria suspension with NO-releasing dendrimers over a
range of concentrations in PBS at 37 °C. At 4 h, 100 μL aliquots of the bacteria suspensions
were removed, diluted 10-fold in PBS, plated on TSA, and incubated overnight at 37 °C.
The minimum concentration of NO-releasing dendrimers that resulted in a 3-log reduction in
bacterial viability was defined as the planktonic minimum bactericidal concentration
(MBC).
Growth of P. aeruginosa Biofilms
A standard US centers for disease control (CDC) bioreactor (Biosurface Technologies,
Bozeman, MT) was used to grow P. aeruginosa biofilms over a 48 h period. Briefly, medical
grade silicone rubber substrates were mounted in coupon holders prior to assembling the
reactor. The assembled reactor was then autoclaved. The reactor effluent line was clamped
and 1% (v/v) sterile TSB (500 mL) was added aseptically. Subsequently, the reactor was
inoculated with an aliquot (1 mL) of P. aeruginosa (108 CFU/mL in TSB) to achieve a final
concentration ~2 × 105 CFU/mL. The reactor was then incubated at 37 °C for 24 h with
stirring (150 rpm). Following this “batch phase” growth, the reactor media was refreshed
continuously with 0.33% (v/v) TSB at 6 mL/min for another 24 h.
Treatment of P. aeruginosa Biofilms with NO-releasing Dendrimers
P. aeruginosa biofilms grown on silicone rubber substrates were exposed to dendrimers in
PBS with slight agitation (37 °C, 24 h) to determine the minimum bactericidal concentration
(MBC) necessary to elicit a 5-log reduction in viability of the biofilm-based bacteria. At 24
h, samples were sonicated and vortexed to disrupt the biofilm. Aliquots (100 μL) of the cell/
dendrimer suspensions were diluted and plated on TSA and incubated overnight. Bacterial
viability was determined by counting observed colonies. Of note, the limit of detection for
this selected plate counting method is 2.5 × 103 CFU/mL. As such, biofilm growth
conditions were selected to accurately represent a 5-log reduction in viability.
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L929 mouse fibroblasts were grown in DMEM supplemented with 10% (v/v) fetal bovine
serum (FBS) and 1 wt% penicillin/streptomycin, and incubated in 5% (v/v) CO2 under
humidified conditions at 37 °C. After reaching confluency (80%), the cells were trypsinized,
seeded onto tissue-culture treated polystyrene 96-well plates at a density of 3×104 cells/mL,
and incubated at 37 °C for 48 h. The supernatant was then aspirated prior to adding 200 μL
fresh DMEM and 50 μL of NO-releasing dendrimers in PBS to each well. After incubation
at 37 °C for 24 h, the supernatant was aspirated and a 120 μL mixture of DMEM/MTS/PMS
(105/20/1, v/v/v) was added to each well. The absorbance of the resulting colored solution
after 1.5 h incubation at 37 °C was quantified using a Thermoscientific Multiskan EX plate
reader at 490 nm. The mixture of DMEM/MTS/PMS and untreated cells were used as a
blank and control, respectively. Cell viability was calculated as follows (Eq. 1):
Eq. 3.1
Confocal Microscopy for Association of Dendrimers with Bacteria Cells
Fluorescently-labeled control and NO-releasing dendrimers were prepared following a
previously reported procedure.44 Briefly, G1-PAMAM-NH2 (100 mg) and rhodamine B
isothiocyanate (RITC) (3 mg) were dissolved in 2 mL methanol. The solution was stirred for
3 d in the dark. The product solution was dialyzed against 0.1 M NaCl (2 L) for 24 h, and
ultrapure Milli-Q water for 3 d (3 × 2 L). Subsequent lyophilization yielded RITC-labeled
G1-PAMAM-NH2. The fluorescently-labeled G1-PAMAM-NH2 dendrimers were modified
with one molar equivalent of PO or ED alone, or a PO/ED mixture, and further reacted with
NO at 10 atm under basic conditions as described above to yield NO-releasing G1-PAMAM
dendrimers. P. aeruginosa was cultured in TSB to a concentration of 1 × 108 CFU/mL,
collected via centrifugation (3645 × g for 10 min), resuspended in sterile PBS, and adjusted
to 1 × 106 CFU/mL. Aliquots of the bacteria solution were incubated in a glass bottom
confocal dish for 2 h at 37 °C. A Zeiss 510 Meta inverted laser scanning confocal
microscope with a 543 nm HeNe excitation laser and a LP 585 nm filter was used to obtain
fluorescence images of the RITC-modified dendrimers. The bright field and fluorescence
images were collected using a N.A. 1.2 C-apochromat water immersion lens with a 20×
objective. Solutions of RITC-labeled NO-releasing (400 μg/mL) dendrimers in PBS (1.5
mL) were added to the bacteria solution (1.5 mL) in the glass confocal dish to achieve a
final concentration of 200 μg/mL. Images were collected at 2 h incubation to characterize
the association, if any, of the dendrimers with P. aerugionsa. Dendrimer–bacteria association
within biofilms was also characterized using confocal microscopy. Established biofilms
stained with Syto 9 (10 μM) were incubated with RITC-labeled NO-releasing dendrimers
(50 μg/mL) for 1 h before imaging. A 488 nm Ar excitation laser with BP 505–530 nm filter
was used to image Syto 9 fluorescence. The bright field and fluorescence images were
collected simultaneously using a N.A. 1.2 C-apochromat water immersion lens with a 10×
objective.
Confocal Microscopy for the Detection of Intracellular NO and Cell Death
The efficiency of NO delivery and resulting bacteria death were evaluated as a function of
dendrimer exterior hydrophobicity using confocal microscopy. Bacteria (P. aeruginosa) were
cultured in TSB to a concentration of 1 × 108 CFU/mL, collected via centrifugation (3645 ×
g for 10 min), resuspended in sterile PBS, and adjusted to 1 × 106 CFU/mL in PBS
supplemented with 10 μM DAF-2 DA and 30 μM PI. The bacteria solution (2.5 mL) was
incubated in a glass bottom confocal dish for 45 min at 37 °C. A Zeiss 510 Meta inverted
laser scanning confocal microscope with a 488 nm Ar excitation laser and a BP 505–530 nm
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filter was used to obtain DAF-2 (green) fluorescence images. Red fluorescence images for
PI were obtained using a 543 nm HeNe excitation laser with a BP 560–615 nm filter. The
bright field and fluorescence images were collected by a N.A. 1.2 C-apochromat water
immersion lens with a 40× objective. An aliquot (1.5 mL) of NO-releasing dendrimers (10
μg/mL) in PBS (supplemented with 10 μM DAF-2 DA and 30 μM PI) was added to the
bacteria solution (1.5 mL) in the glass confocal dish. Images were collected every 5 min to
observe intracellular NO concentrations (green fluorescence) and compromised bacteria
membrane (red fluorescence) temporally. The efficiency of NO delivery to bacteria within
biofilms was also evaluated as a function of dendrimer composition by incubating the P.
aeruginosa biofilm with NO-releasing dendrimers (20 μg/mL) in PBS supplemented with 10
μM DAF-2 DA and 30 μM PI for 1 h. Bright field and fluorescence images were collected
using a N.A. 1.2 C-apochromat water immersion lens with a 20× objective.
Results and Discussion
Sun et al. previously reported on the planktonic biocidal activity of NO-releasing dendrimers
as a function of exterior functionality.44 Functionalization with hydrophobic groups at the
dendrimer exterior improved bactericidal efficacy but also resulted in significant toxicity
towards mammalian cells. Even low concentrations (< 50 μg/mL) of hydrophobic dendrimer
resulted in ~80% killing of L929 mouse fibroblast cells.44 We thus sought to synthesize NO-
releasing dendrimers with tunable exterior hydrophobicity in order to fully evaluate the
impact of dendrimer structure on both bactericidal action and cytotoxicity.
Synthesis of Nitric Oxide Donor-Modified PAMAM Dendrimers
Secondary amine-functionalized dendrimers with diverse exterior functionalities were
prepared using epoxides ring opening reactions with primary amines on the dendrimer
exterior.32 N-diazeniumdiolate NO donors were formed by reaction of the resulting
secondary amines with NO gas under basic conditions.32 To synthesize secondary amine-
functionalized dendrimer with varied exterior hydrophobicity, poly(amidoamine) (PAMAM)
dendrimers were modified by a similar ring opening reaction using either hydrophilic PO
exclusively, hydrophobic ED exclusively, or varying molar ratios of PO and ED as shown in
Scheme 1.
The PO, ED, and PO/ED mixtures were added in a total of one equivalent with respect to the
molar concentration of PAMAM primary amine functionality. The actual ratio of PO and
ED conjugated to the PAMAM dendrimers was determined using 1H NMR spectroscopy.
As shown in Figure 1, a distinct resonance at 3.82 ppm corresponded to the methyne protons
adjacent to the hydroxyl group of the product.
This chemical shift was observed in the products of dendrimer reacting with PO exclusively,
as well as those with a PO/ED mixture. The NMR spectra also reveal the presence of a
second distinct peak at 5.80 ppm, formed upon reaction of the dendrimer with either ED
exclusively or the PO/ED mixtures. The 5.80 ppm peak corresponds to the methyne protons
of the unsaturated ED double bond. The integration of the 3.82 and 5.80 ppm peaks allowed
for the determination of the molar ratio of PO and ED. For PO/ED bifunctionalized
dendrimers, the feed molar ratio of PO and ED was tuned to yield PO/ED ratios of 7:3 (i.e.,
G1-PE 73, G3-PE 73), 5:5 (i.e., G1-PE 55), and 3:7 (i.e., G1-PE 37). In this manner, we
were able to study the effects of relative hydrophobicity on bactericidal activity and
cytotoxicity (Table 1). In addition, work by Sun et al. indicated the importance of dendrimer
size (i.e., dendrimer generation) on bactericidal efficacy, with higher generation (i.e., larger)
NO-releasing dendrimers being more effective at killing bacteria due to greater NO
payloads.44 Multivalent dendrimer-bound NO donors with 8 (G1) and 32 (G3) terminal
functional groups were thus synthesized to understand the influence of dendrimer size on the
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anti-biofilm efficacy against P. aeruginosa biofilms. Subsequent reaction of the secondary
amine-functionalized dendrimers (e.g., PO, ED, PE) with NO at 10 atm under basic
conditions (Scheme 1) produced N-diazeniumdiolate-functionalized dendritic scaffolds (e.g.,
PO-NO, ED-NO, PE-NO).
The dendrimers exhibited similar NO storage (~1 μmol/mg) and NO-release kinetics (i.e.,
half life ~1 h) regardless of modification (Table 1). Of note, similar total NO storage and
NO-release kinetics for the PO/ED (PE)-functionalized dendrimers were expected since both
100% PO or ED-functionalized dendrimers exhibited a total NO storage of ~1 μmol/mg and
a half-life of ~1 h. These NO-release properties facilitate the evaluation of how surface
hydrophobicity (via the PO to ED ratio) and dendrimer generation impact NO delivery and
bacteria killing.
Bactericidal Studies: Planktonic Bacteria
Planktonic Gram-negative P. aeruginosa were exposed to control and NO-releasing
dendrimers to evaluate the effects of the PO/ED ratio on bacterial killing. The bacterial
viability assays were carried out over a 4-h period under static conditions. The concentration
of dendrimer required to reduce bacteria viability by 3-logs was determined for each
dendrimer structure; hereafter, this concentration is referred to as the planktonic minimum
bactericidal concentration or MBC. The bactericidal NO dose for the NO-releasing
dendrimers was also determined by multiplying the total NO dose over 4 h (i.e., t[NO]a) and
the corresponding MBC. As shown in Table 2, the amphiphilic control dendrimers
functionalized with ED exclusively or a PO/ED mixture (e.g., G1-ED, G1-PE 37, G1-PE
55, G1-PE 73) exhibited enhanced biocidal activity against planktonic P. aeruginosa
compared to the hydrophilic control dendrimer (G1-PO). This behavior is in part attributed
to the enhanced perturbation and disruption of the bacteria membrane by the amphiphilic
structures.47 Functionalizing 30% of the dendrimer exterior primary amines with ED (i.e.,
G1-PE 73) improved the biocidal action of the dendrimer scaffold by 99% (i.e., the MBC
for G1-PE 73 and G1-PO was 30 and 3000 μg/mL, respectively) compared to dendrimers
functionalized solely with PO (i.e., G1-PO).
Further inspection of the data revealed lower MBCs for NO-releasing dendrimers compared
to their non-NO-releasing counterpart, indicating enhanced bactericidal activity with NO.
This increase in bactericidal efficacy is attributed to the oxidative and nitrosative stresses
resulting from NO.31 As shown in Table 2, the bactericidal NO dose required to elicit the 3-
log reduction in bacterial viability decreased with increasing dendrimer hydrophobicity (i.e.,
ED content), suggesting enhanced bacterial killing. For example, the bactericidal NO doses
for G1-ED-NO and G1-PO-NO were 3.55 and 182 nmol/mL, respectively. Since dendrimer
association with the outer surface (i.e., membrane) of bacteria followed by penetration
through the bacteria membrane has been identified previously as an important killing
mechanism,23 we hypothesized that increasing the ED (hydrophobic) content of the
dendrimer exterior would improve dendrimer association with the bacteria and facilitate
more efficient NO delivery. Confocal microscopy was thus used to characterize the
association of RITC-labeled G1-PE 73-NO, G1-PE 55-NO, G1-PE 37-NO, and G3-PE 73-
NO with planktonic P. aeruginosa (Figure 2). Dendrimers were labeled with RITC following
a previous report.44 The impact of the RITC label on the dendrimer–bacteria association was
minimized by using a low amount of RITC (i.e., 1:100 molar ratio to total primary amines).
As expected, based on hydrophobicity, the red fluorescence intensity was the greatest from
RITC-labeled G1-PE 55-NO and G1-PE 37-NO, indicating more rapid association of these
dendrimers with P. aeruginosa than G1-PE 73-NO. However, the association of G1-PE 37-
NO and G1-PE 55-NO with P. aeruginosa were similar, illustrating that the improvement of
dendrimer association due to hydrophobicity likely plateaus at ~50% ED functionality (G1-
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PE-55-NO). Additional ED modification had negligible influence on the dendrimer-bacteria
association kinetics. The association of the larger dendrimer (G3-PE 73-NO) was similar to
that of G1-PE 73-NO, indicating that the hydrophobicity of the dendritic scaffolds plays a
greater role in bacteria association than size, at least for G1 vs. G3 dendrimers. Other sizes
and bacteria may result in altered behavior in dendrimer–bacteria association.
Based on enhanced dendrimer–bacteria association for dendrimers with greater ED
character, we predicted more effective NO delivery and greater bacteria damage (i.e.,
membrane disruption). Fluorescence from DAF-2 (green) and PI (red) molecular probes
were employed to study the intracellular NO levels and ensuing membrane disruption,
respectively, using confocal microscopy. Green fluorescence (DAF-2) was nearly always
observed first, indicating a buildup of intracellular NO. Red fluorescence (PI) followed as
the bacteria membrane became compromised, with concomitant diminished green
fluorescence. The buildup of measurable intracellular NO for bacteria incubated with G1-
PE 37-NO, G1-PE 55-NO, and G3-PE 73-NO was observed at 35 min (Figure 3),
significantly earlier than bacteria incubated with G1-PE 73-NO (60 min). The more rapid
association (G1-PE 37-NO and G1-PE 55-NO) with bacteria and greater localized NO
release (G3-PE 73-NO) allowed for faster NO accumulation and biocidal action.
Indeed, red fluorescence (PI) was observed at 55, 75, 135, and 70 min for G1-PE 37-NO,
G1-PE 55-NO, G1-PE 73-NO, and G3-PE 73-NO, respectively. The confocal images of
bacteria incubated with G1-PE 37-NO, G1-PE 55-NO, G1-PE 73-NO, and G3-PE 73-NO
at 135 min were also used to compare the bactericidal activity of the dendrimers. As shown
in Figure 4, bacteria incubated with G1-PE 37-NO, G1-PE 55-NO, and G3-PE 73-NO
were characterized as having compromised membranes. Conversely, bacteria incubated with
G1-PE 73-NO exhibited DAF-2 fluorescence, but maintain their membrane integrity (i.e.,
low PI fluorescence), confirming the enhanced bactericidal activity of larger generation
dendrimers and those with greater exterior hydrophobicity.
Bactericidal Studies: Biofilm Eradication
Although planktonic killing assays are helpful in determining a drug or antibacterial agent’s
potential biomedical utility, most bacteria establish biofilms as a protective mechanism
against therapeutics.1 To evaluate the effects of PO/ED ratio and dendrimer size on the anti-
biofilm activity of NO-releasing amphiphilic dendrimers, P. aeruginosa biofilms were
exposed to a range of NO-releasing dendrimer concentrations (10–800 μg/mL) for 24 h.
Following treatment, the biofilm was forced off of the substrate and dispersed by vortexing
and sonication to enable viability quantification. Control experiments were performed to
confirm both the growth of P. aeruginosa biofilms under the selected conditions and the
negligible effect of vortexing/sonication on bacteria viability when incubated only in PBS.
The viability of bacteria embedded in biofilms was ~2×108 CFU per biofilm. Considering
the detection limit of 2,500 CFU/mL for this selected plate counting method, a maximum of
5-log reduction in bacterial viability can be achieved. The lowest concentration for a 5-log
reduction in bacterial viability (minimum bactericidal concentration or MBC) was then used
to characterize the antibacterial efficacy of the amphiphilic dendrimers. The bactericidal NO
dose for each of the NO-releasing dendrimers was also derived by multiplying the total NO
release over 24 h (t[NO]b) with the corresponding MBCs (Table 3).
Analogous to the inherent bacterial killing observed for planktonic P. aeruginosa, the
amphiphilic control dendrimers (G1-PE 73, G1-PE 55, G1-PE 37, and G1-ED) proved
more effective at killing bacterial biofilms than the hydrophilic dendrimer (G1-PO) due to
the membrane disruption properties by the amphiphilic structures. Dendrimer MBCs for
biofilm eradication (5-log killing) were 10000, 150, 30, 15, and 25 μg/mL for G1-PO, G1-
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PE 73, G1-PE 55, G1-PE 37, and G1-ED, respectively. As expected, NO release improved
the bactericidal activity of the dendrimers with reduced MBCs (i.e., 800, 80, 20, 10, and 15
μg/mL for G1-PO-NO, G1-PE 73-NO, G1-PE 55-NO, G1-PE 37-NO, and G1-ED-NO,
respectively). Of the dendrimer systems studied, G1-PE 37-NO exhibited the greatest anti-
biofilm efficacy indicated by the lowest MBC (10 μg/mL) and corresponding bactericidal
NO dose (11 nmol/mL). To evaluate the enhanced bactericidal activity of G1-PE 37-NO
and whether it could be attributed to more rapid association with bacteria embedded within
the biofilms, the association of G1-PE 73-NO, G1-PE 37-NO, and G1-ED-NO with
bacteria in P. aeruginosa biofilms was characterized using confocal microscopy. As shown
in Figure 5, a greater number of bacteria in the biofilms exhibited red fluorescence upon
incubation with RITC-labeled G1-PE 37-NO compared to G1-PE 73-NO. As for planktonic
bacteria, the enhanced hydrophobic interaction between the dendrimer and bacteria
membrane facilitates more efficient NO delivery and killing bacteria (e.g., membrane
disruption). Despite the greater hydrophobicity of G1-ED-NO, less dendrimer–bacteria
association was noted for G1-ED-NO compared to G1-PE 37-NO. We currently attribute
this result to less efficient EPS penetration due to the greater hydrophobicity of G1-ED-
NO.48
Similarly, Wicke et al. reported inhibited diffusion of hydrophobic organic molecules within
microbial biofilms compared to hydrophilic derivatives.48 G1-PE 37-NO proved to be the
most effective dendrimer construct for eradicating the biofilm bacteria because of its rapid
penetration into the biofilm and association with bacteria. Perhaps unexpectedly, dendrimer
size (i.e., dendrimer generation) only slightly impacted bacteria association in the P.
aeruginosa biofilm studies. Although G3-PE 73-NO exhibited similar association with
bacteria compared to G1-PE 73-NO, the DAF-2 fluorescence from biofilms incubated with
the larger (G3) dendrimer indicated greater intracellular NO delivery (Figure 6). As noted by
the lower required dose to eradicate the bacteria, this increased NO payload and delivery
from the larger generation dendrimer (G3-PE 73-NO) proved more bactericidal.
Cytotoxicity of NO-Releasing Dendrimers
Although effective at eradicating biofilms, Sun et al. reported that amphiphilic NO-releasing
dendrimers were toxic to mammalian cells.44 For example, polypropylenimine dendrimers
modified with styrene oxide elicited substantial toxicity (i.e., >80% reduction in viability at
>34 μg/mL) towards L929 mouse fibroblast cells, whereas dendrimers modified with
hydrophilic PO elicited no toxicity at concentrations up to 500 μg/mL. Based on these
results, we hypothesized that the ratio of hydrophobic (ED)/hydrophilic (PO)
functionalization would influence the cytotoxicity of the amphiphilic NO-releasing
dendrimers reported herein. Cytotoxicity to L929 mouse fibroblast cells was thus evaluated
at the dendrimer concentrations necessary for 3- and 5-log reductions in bacteria viability
measured for the planktonic and biofilm P. aeruginosa assays, respectively, using the MTS
assay (24 h incubation).
Normalized L929 mouse fibroblast cell viabilities of NO-releasing and control dendrimers at
the planktonic and biofilm bacteria MBCs are shown in Figure 7A and 7B, respectively. In
general, the NO-releasing dendrimers were less toxic than their control counterparts due to
the lower concentration of dendrimer required for planktonic killing and biofilm eradication.
As expected, dendrimers with increased hydrophobic character (e.g., G1-ED-NO and G1-
PE 37-NO) exhibited greater cytotoxicity (i.e., ~70% cell viability reduction) after 24 h
incubation at the MBCs against P. aeruginosa biofilms, likely the result of membrane
disruption by the large density of hydrophobic chains on the dendrimer periphery.
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The most hydrophilic dendrimer, G1-PO-NO, was also toxic at its corresponding MBC (800
μg/mL) due to the concentration required to eradicate the biofilm-embedded bacteria.
Dendrimers with intermediate ratios of PO/ED (e.g., G1-PE 55-NO and G1-PE 73-NO)
exhibited significantly lower cytotoxicity at the MBCs required to kill the biofilm bacteria.
The reduced cytotoxicity is clearly the result of both the lower concentrations of dendrimers
required to deliver sufficient levels of NO and the lower ED content on the dendrimer
exterior compared to G1-ED-NO and G1-PE 37-NO. Clearly, the PO/ED ratio at the
dendrimer exterior has a significant impact on overall cytotoxicity. Despite the enhanced
bactericidal action against biofilms, G1-PE 37-NO and G1-ED-NO also elicited toxicity
towards L929 cells as a result of the ED-induced membrane disruption properties. The larger
dendrimer constructs (e.g., G3-PE 73-NO) were found to be slightly more toxic (~10%
reduction in cell viability) to the L929 mouse fibroblast cells compared to G1-PE 73-NO at
their respective MBCs, corroborating results by Sun et al. who reported similar generation
dependent-cytotoxicity of NO-releasing dendrimers to L929 cells (larger generation being
more toxic).44 The favorable toxicity of the antibacterial G1-PE 55-NO, G1-PE 73-NO,
and G3-PE 73-NO dendrimers over previously reported hydrophobic polypropylenimine
dendrimers44 indicate the advantage of using amphiphilic NO-release vehicles with
intermediate exterior hydrophobicity (e.g., G1-PE 55-NO, G1-PE 73-NO) to maximize
bacteria killing while minimizing toxicity to mammalian cells.
Conclusions
The utility of amphiphilic NO-releasing dendrimers as antibacterial agents was
demonstrated through the systematic study of killing efficiency as a function of NO-
releasing dendrimer hydrophobicity and dendrimer size (i.e., dendrimer generation). In
particular, the hydrophobicity of dendrimer surface groups were found to significantly
influence dendrimer association with P. aeruginosa bacteria, the efficiency of intracellular
NO delivery, the extent of bacteria membrane disruption, and the cytotoxicity to mammalian
cells. Optimal antibacterial activity with minimal toxicity toward mammalian cells was
achieved by modifying the dendrimer exterior with a mixture of hydrophilic (PO) and
hydrophobic (ED) functionalities. Roughly equal PO/ED modification proved most
effectively at eradicating P. aeruginosa biofilms with minimal impact on L929 mouse
fibroblast cell viability. Future studies should include testing of these materials against
polymicrobial biofilms, biofilms formed from clinically-isolated bacteria, and detailed
pharmacological toxicity evaluation of the NO-releasing dendrimers using human cells/
tissues.
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1H NMR spectra of A) G1-PAMAM-ED, B) G1-PAMAM-PE 37, C) G1-PAMAM-PE
55, D) G1-PAMAM-PE 73, and E) G1-PAMAM-PO. The actual composition of ED and
PO was determined by the integration of peaks at 5.80 (-CH=CH2) and 3.82 (-CH(OH)CH3)
ppm.
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Bright field/fluorescent overlay and fluorescent images of RITC-label NO-releasing
dendrimers association with planktonic P. aeruginosa. A) G1-PE 73; B) G1-PE 55; C) G1-
PE 37; D) G3-PE 73. Scale bar 5 μm. Image on the right are color and best observed
electronically.
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Intracellular DAF-2 (green) and PI (red) fluorescence from planktonic P. aeruginosa
exposed to NO-releasing dendrimers G1-PE 37-NO at A-35, B-50, C-55, D-65, E-105,
F-110 min, G1-PE 55-NO at A) 35, B) 60, C) 75, D) 85, E) 115, F) 150 min, G1-PE 73-NO
at A) 60, B) 85, C) 125, D) 135, E) 140, F) 150 min, and G3-PE 73-NO at A) 35, B) 50, C)
65, D) 70, E) 100, F) 130 min. Intracellular NO is indicated by the DAF-2 green
fluorescence, whereas PI red fluorescence points to compromised membranes. Scale bar: 2
μm.
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Intracellular DAF-2 (green) and PI (red) fluorescence from planktonic P. aeruginosa
exposed to NO-releasing dendrimers at 135 min incubation A) G1-PE 37-NO; B) G1-PE
55-NO; C) G1-PE 73-NO; and D) G3-PE 73-NO. Scale bar: 5 μm.
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Three dimentional scanning confocal microscopy images of P. aeruginosa biofilms exposed
to A) G1-PE-37-NO; B) G1-ED-NO; C) G1-PE 73-NO; and D) G3-PE 73-NO RITC-
labeled NO-releasing dendrimers for 1 h incubation. Greater red fluorescence indicates more
efficient dendrimer–bacteria association. Scale bar: 300 μm.
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Three dimensional intracellular DAF-2 fluorescence images of P. aeruginosa biofilms
incubated with A) G1- and B) G3-PE 73-NO for 1 h. Scale bar: 50 μm. Green fluorescence
indicates the intracellular NO levels.
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Cytotoxicity of NO-releasing dendrimers to L929 fibroblast cells at the MBCs against A)
planktonic and B) biofilm-based P. aeruginosa.
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Synthesis of secondary amine- and N-diazeniumdiolate-functionalized PAMAM conjugates
for which n represents the number of primary amines on the periphery of PAMAM
dendrimers (n = 8, 32).1
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Table 2
Comparison of the minimum bactericidal concentration (MBC) and bactericidal NO doses of control and NO-
releasing dendrimers against planktonic Gram-negative P. aeruginosa after 4 h exposure for 3-log reduction in
bacterial viability.
Dendrimers MBCa (μg/mL) MBCb (μg/mL) Bactericidal NO Doses (nmol/mL)
G1-ED 8 5 3.55
G1-PE 37 5 4 3.72
G1-PE 55 10 7 7.70
G1-PE 73 30 20 17.6
G1-PO 3000 200 182
G3-PE 73 20 15 13.4
a
concentration of control dendrimer required to reduce bacterial viability by 3-logs.
b
concentration of NO-releasing dendrimer required to reduce bacterial viability by 3-logs.
Each parameter was analyzed with multiple replicates (n=3).
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Table 3
Comparison of the minimum bactericidal concentration and bactericidal NO doses of control and NO-
releasing dendrimers required to achieve 5-log reduction in bacteria viability of Gram-negative P. aeruginosa
biofilms after 24 h exposure.
MBCa (μg/mL) MBCb (μg/mL) Bactericidal NO Doses (nmol/mL)
G1-ED 25 15 18.5
G1-PE 37 15 10 11.0
G1-PE 55 30 20 24.6
G1-PE 73 150 80 83.2
G1-PO 10000 800 824
G3-PE 73 150 60 63.6
a
concentration of control dendrimer required to reduce bacterial viability by 5-logs.
b
concentration of NO-releasing dendrimer required to reduce bacterial viability by 5-logs.
Each parameter was analyzed with multiple replicates (n=3).
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